Lead, Digital Marketing
Harrow
Summary
Owns Harrow's enterprise digital marketing platform across all three franchises: social media, omnichannel campaigns, paid media, website and SEO, and digital measurement. Runs one shared intake queue so every brand gets digital capability without duplicating headcount.
Job description
Position Summary
Owns Harrow's enterprise digital marketing platform across all three franchises: social media, omnichannel campaigns, paid media, website and SEO, and digital measurement. Runs one shared intake queue so every brand gets digital capability without duplicating headcount.
Core Responsibilities
- Set the digital, social, and omnichannel strategy for all franchises and Harrow corporate channels, built on HCP and patient journeys.
- Run the shared intake queue, prioritizing requests from the franchise pillars and platforms based on demand impact.
- Own paid media planning and buying for HCP and consumer audiences with agency partners.
- Own website, SEO, and content strategy; govern modular content and asset reuse.
- Define segmentation, personalization, and channel mix rules using Analytics.
- Own digital KPIs and dashboards; report channel ROI to the Head of Marketing.
- Partner with Marketing & Commercial Operations, which administers the CRM and martech stack, on the technology roadmap.
- Lead and develop social and digital marketer(s).
- Develop field-facing digital tools and integrate digital into field efforts with Sales.
- Amplify KOL content platforms (e.g., video series) across digital and social channels.
- Bring digital programs into launches, lifecycle marketing, and congress initiatives.
- Serve as the subject-matter expert and brand ambassador for Harrow's digital and social presence, internally and externally.
- Partner with the Thought Leader/ProEd lead and maintain regular contact with thought leaders, influencers, and key stakeholder groups to gather insights and market intelligence, including spending time in the field with Sales to observe how materials and messaging are delivered and received in market.
Qualifications & Requirements
- Bachelor's degree; 10+ years in digital marketing, including 6+ in pharma, biotech, or healthcare; prior agency experience a plus.
- Hands-on with at least three channels: web, email, paid social, programmatic, SEM/SEO.
- Built omnichannel programs using CRM data.
- Has taken digital assets through PRC/MLR review; knows FDA promotional, privacy, and social-media rules.
- 3+ years managing people and agencies.
- Demonstrated experience with SEM, SEO, web analytics, and Google Ads.
- Proficiency with AI platforms such as ChatGPT and Claude, and with Slack.
Preferred Qualifications
- HCP media planning and marketing-mix measurement.
- Proficiency with Salesforce, Pardot/HubSpot/etc., Power BI, and Google Analytics; Adobe Suite a plus.
Position Type
Remote (U.S.)
Travel
Approximately 25%
Requirements
- Bachelor's degree
- 10+ years in digital marketing
- 6+ years in pharma, biotech, or healthcare
- Hands-on with at least three channels: web, email, paid social, programmatic, SEM/SEO
- Built omnichannel programs using CRM data
- Experience taking digital assets through PRC/MLR review
- Knowledge of FDA promotional, privacy, and social-media rules
- 3+ years managing people and agencies
- Demonstrated experience with SEM, SEO, web analytics, and Google Ads
- Proficiency with AI platforms such as ChatGPT and Claude
- Proficiency with Slack
Benefits
- Remote (U.S.)
- Bonus
- ~25% Travel
Company overview
Harrow Health, Inc. (NASDAQ: HROW) is a publicly traded pharmaceutical company headquartered in Nashville, Tennessee, specializing in ophthalmic healthcare solutions. Founded in 2012 and formerly known as Imprimis Pharmaceuticals, the company has established itself as a growing leader in the ophthalmic pharmaceutical market. Harrow operates through multiple subsidiaries including ImprimisRx, its compounding pharmacy business that produces cGMP ophthalmic eye drops and sterile compounded products. The company's core mission focuses on providing affordable and accessible medications while maintaining an unyielding dedication to innovation. Harrow gained significant attention for developing low-cost alternatives to expensive medications, most notably creating a $1 per pill alternative to Daraprim during the Martin Shkreli controversy. The company's business model emphasizes developing inexpensive alternatives to off-patent medicines where single manufacturers charge excessive prices. With a portfolio that includes branded, generic, and compounded ophthalmic medications, Harrow serves healthcare providers and patients across the United States through its FDA-registered outsourcing facilities and nationwide distribution network.